BioSig Technologies Inc. (BSGM) stock hits $1.50: Is it a good time to buy or wait for a dip?

As of right now, BioSig Technologies Inc. [BSGM] is trading at $1.50, up 3.08%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BSGM shares have gain 1.01% over the last week, with a monthly amount glided 22.36%, and seem to be holding up well over a long-time horizon.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.

Sponsored

On 25, May 2023, New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market. In a post published today on Yahoo Finance, Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA, last week. The platform’s precision signal-capturing technology is meant to improve the speed, accuracy and precision of cardiac ablation, a widely-used surgery to treat atrial fibrillation. All three studies showed significant improvements over the conventional methods used for the procedure, putting BioSig on track for a successful commercial launch of the platform in a global cardiac ablation market projected to exceed $14 billion by 2032.

From an analyst’s perspective:

Through the last year, BioSig Technologies Inc.’s stock price ranged from $0.25 to $1.58. Currently, Wall Street analysts expect the stock to reach $3.63 within the next 12 months. BioSig Technologies Inc. [NASDAQ: BSGM] shares were valued at $1.50 at the most recent close of the market. An investor can expect a potential return of 142.0% based on the average BSGM price forecast.

Analyzing the BSGM fundamentals

For BioSig Technologies Inc., (BSGM), the latest quarter sales were 5.0 million, which represents an -37.50% decrease. Gross Margin for this corporation currently stands at -152.80% with Operating Margin at -9533.22%, Pretax Margin comes in at -9532.17%, and Net Margin reading is -9458.74%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4200 points at the first support level, and at 1.3350 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6200, and for the 2nd resistance point, it is at 1.7350.

BioSig Technologies Inc. [BSGM] reported earnings per share of -$0.12 for its fiscal quarter that ended on 3/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.1/share, meaning a difference of -$0.02 and a surprise factor of -20.00%. By comparison, the stated earnings for the previous quarter ended on 12/30/2022 were -$0.14 per share as compared to estimates of -$0.12 per share, a difference of -$0.02 representing a surprise of -16.70%.

Ratios To Look Out For

It is important to note that BioSig Technologies Inc. [NASDAQ:BSGM] has a current ratio of 0.80. Also, the Quick Ratio is 0.24, while the Cash Ratio stands at 0.11. Considering the valuation of this stock, the price to sales ratio is 62.61, the price to book ratio is 73.30.

Transactions by insiders

Recent insider trading involved Sieckhaus John, Chief Operating Officer, that happened on Sep 12 when 5000.0 shares were purchased. Chief Executive Officer, LONDONER KENNETH L completed a deal on Sep 09 to buy 29700.0 shares. Meanwhile, Chief Executive Officer LONDONER KENNETH L bought 22766.0 shares on Sep 08.